Breaking Finance News

Evonik Industries (ETR:EVK) stock price target bumped up to 34.00EUR, reported today by Bernstein Research

Yesterday Evonik Industries (ETR:EVK) traded 4.60% lower at 29.44EUR. Evonik Industries’s 50-day moving average is 2.57EUR and its 200-day average is 2.03EUR. The last stock price close is up 12.34% from the 200-day average, compared to the Standard & Poor’s 500 Index which has fallen -0.01% over the same time. 12,913 shares of EVK traded hands, up from ann avg. volume of 6,409.

Bernstein Research upped the target stock price of Evonik Industries (ETR:EVK) to 34EUR, reporting a possible upside of 0.15%,

On 9/18/2016, Citigroup Corp. released a statement about Evonik Industries(ETR:EVK) upped the target price from 0.00EUR to 38.00EUR. At the time, this suggested an upside of 0.31%.

See Chart Below:

Evonik Industries (ETR:EVK)

Evonik Industries has a PE of 3 with a 52 week low of 1.35EUR and a one-year high of 3.67EUR and has a market capitalization of 0.0 EUR.

General Information About Evonik Industries (ETR:EVK)

Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company’s activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company’s sites, and among others. It is a subsidiary of RAG Stiftung.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.